Study of CD36 Gene and Its Alternative Promoters
Author Information
Author(s): Malin Andersen, Boris Lenhard, Carl Whatling, Per Eriksson, Jacob Odeberg
Primary Institution: Royal Institute of Technology (KTH)
Hypothesis
The study investigates the expression patterns of five alternative first exons of the CD36 gene in various human tissues and cell types.
Conclusion
The alternative first exons of the CD36 gene are regulated individually and tissue specifically, with all exons upregulated in response to oxidized low density lipoproteins in THP-1 macrophages.
Supporting Evidence
- Five alternative first exons of the CD36 gene were identified and confirmed.
- Expression patterns of the alternative first exons varied significantly across different tissues.
- All alternative first exons were upregulated in THP-1 macrophages in response to oxidized low density lipoproteins.
Takeaway
Scientists looked at how different parts of a gene called CD36 work in different body tissues, and found that they can turn on or off depending on the tissue and conditions.
Methodology
The study used real-time RT-PCR to analyze the expression levels of alternative first exons in various human tissues and cell types.
Limitations
The study does not explore the full range of potential regulatory mechanisms affecting CD36 expression.
Participant Demographics
Healthy donors provided monocyte samples for analysis.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website